Sertraline in diabetic neuropathy: Preliminary results

Annals of Clinical Psychiatry

Volumn 9, Issue 4, 1997, Pages 255-257

  Goodnick, Paul J ^a   Jimenez, Isabel ^a   Kumar, Adarsh ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Blood levels; Diabetes mellitus; Neuropathy; Pain; Serotonin treatment

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; DIABETIC NEUROPATHY; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; PAIN; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; SELF REPORT; STATISTICAL ANALYSIS; THROMBOCYTE;

1-NAPHTHYLAMINE; ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIDEPRESSIVE AGENTS; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PERSONALITY INVENTORY; SERTRALINE; SICK ROLE; TREATMENT OUTCOME;

EID: 0031426181     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022360528151     Document Type: Article

References (12)

1. Goodnick PJ, Henry JH, Buki VMV: Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995; 56:128-136
2. Wilson GA, Furman BL: Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycemia in mice. Eur J Pharmacol 1982; 78:263-270
3. Wilson JD, Braunwald E, Isselbacherr, et al.: Harrison's Principles of Internal Medicine, 12th ed., New York: McGraw-Hill; 1991
4. Andreoli TE, et al., eds.: Cecil Essentials of Medicine. Philadelphia: Saunders; 1990
5. Sindrup SH: Antidepressants in the treatment of diabetic neuropathy symptoms. Danish Med Bull 1994; 41:66-78
6. Max MB, Lynch SA, Muir J, et al.: Effects of desipramine, amitriptyline, and fluoxetine in diabetic neuropathy. N Engl J Med 1992; 326:1250-1256
7. Sindrup SH, Gram LF, Skjold T, et al.: Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms: A double-blind crossover study. Br J Clin Pharmacol 1990; 30:683-691
8. Sindrup SH, Grodum E, Gram LF, et al.: Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: A patient-blinded dose-escalation study. Ther Drug Monit 1991; 13:408-414
9. Goodnick PJ, Kumar A, Henry JH, et al.: Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull, 1997; 33:261-264
10. Kumar AM, Kumar M, Krishnaprasad D: A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelets, and plasma. Life Sci 1990; 47:1751-1759
11. Goodnick PJ, Benitez A: New antidepressant agents: Recent pharmacological developments leading to improved efficacy. Exp Opin Invest Drugs 1995; 4:935-943
12. Goodnick PJ, Henry J, Kumar A: Neurochemistry and paroxetine response in major depression. Biol Psychiatry 1995; 37:417-419